Cite
Sjoberg HT, Philippou Y, Magnussen AL, et al. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. Br J Cancer. 2021;125(4):534-546doi: 10.1038/s41416-021-01450-6.
Sjoberg, H. T., Philippou, Y., Magnussen, A. L., Tullis, I. D. C., Bridges, E., Chatrian, A., Lefebvre, J., Tam, K. H., Murphy, E. A., Rittscher, J., Preise, D., Agemy, L., Yechezkel, T., Smart, S. C., Kinchesh, P., Gilchrist, S., Allen, D. P., Scheiblin, D. A., Lockett, S. J., Wink, D. A., Lamb, A. D., Mills, I. G., Harris, A., Muschel, R. J., Vojnovic, B., Scherz, A., Hamdy, F. C., & Bryant, R. J. (2021). Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. British journal of cancer, 125(4), 534-546. https://doi.org/10.1038/s41416-021-01450-6
Sjoberg, Hanna T, et al. "Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer." British journal of cancer vol. 125,4 (2021): 534-546. doi: https://doi.org/10.1038/s41416-021-01450-6
Sjoberg HT, Philippou Y, Magnussen AL, Tullis IDC, Bridges E, Chatrian A, Lefebvre J, Tam KH, Murphy EA, Rittscher J, Preise D, Agemy L, Yechezkel T, Smart SC, Kinchesh P, Gilchrist S, Allen DP, Scheiblin DA, Lockett SJ, Wink DA, Lamb AD, Mills IG, Harris A, Muschel RJ, Vojnovic B, Scherz A, Hamdy FC, Bryant RJ. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. Br J Cancer. 2021 Aug;125(4):534-546. doi: 10.1038/s41416-021-01450-6. Epub 2021 Jun 21. PMID: 34155340; PMCID: PMC8367986.
Copy
Download .nbib